12S-hydroxy-5E,8Z,10Z,14Z-eicosatetraenoic acid
|
Basic information |
| Metabolite name | 12S-hydroxy-5E,8Z,10Z,14Z-eicosatetraenoic acid |
 | HMDB0062287 |
 |
N/A |
 |
N/A |
| Synonyms | 12(R)-HETE; |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | 12S-hydroxy-5E,8Z,10Z,14Z-eicosatetraenoic acid |
| HMDB0062287 |
|
N/A |
|
N/A |
| Synonyms | 12(R)-HETE; |
| No. of studies | 3 |
|
Relationship between 12S-hydroxy-5E,8Z,10Z,14Z-eicosatetraenoic acid and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1072 | Type1 | CUMS group vs. control group | Intestine | Cynomolgus monkey | Down |
| Study M1073 | Type1 | BDE47 exposure group vs. control group | Faece | C57BL/6 mouse | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running group vs. Abeta oligomer group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |